Evidence map›Paper›PMID 35585549›Full record

ArticleOrphanet journal of rare diseases2022

Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families.

Indraneel Banerjee, Julie Raskin, Jean-Baptiste Arnoux, Diva D De Leon, Stuart A Weinzimer, Mette Hammer, David M Kendall, Paul S Thornton

Abstract readPublished Erratum
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Indraneel BanerjeeDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Oxford Road, Manchester, M13 9WL, UK. indi.banerjee@manchester.ac.uk.ORCID http://orcid.org/0000-0003-4280-7470
Julie RaskinCongenital Hyperinsulinism International, Glen Ridge, NJ, USA.
Jean-Baptiste ArnouxReference Center for Inherited Metabolic Diseases, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
Diva D De LeonDivision of Endocrinology and Diabetes, Department of Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Stuart A WeinzimerDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
Mette HammerZealand Pharma A/S, Søborg, Denmark.
David M KendallZealand Pharma A/S, Søborg, Denmark.
Paul S ThorntonCongenital Hyperinsulinism Center, Cook Children's Medical Center, Fort Worth, TX, USA.

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35585549
PMCPMC9118786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.